Cart
sales@molnova.com
Ralfinamide mesylate
CAS No. 202825-45-4
Ralfinamide mesylate ( FCE-26742A (mesylate) )
Catalog No. M20790 CAS No. 202825-45-4
Ralfinamide mesylate is an orally available Na+ channel blocker.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 259 | Get Quote |
|
| 10MG | 405 | Get Quote |
|
| 25MG | 668 | Get Quote |
|
| 50MG | 888 | Get Quote |
|
| 100MG | 1251 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameRalfinamide mesylate
-
NoteResearch use only not for human use.
-
Brief DescriptionRalfinamide mesylate is an orally available Na+ channel blocker.
-
DescriptionRalfinamide mesylate is an orally available Na+ channel blocker.
-
SynonymsFCE-26742A (mesylate)
-
PathwayMembrane Transporter/Ion Channel
-
TargetSodium Channel
-
RecptorSodium Channel
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number202825-45-4
-
Formula Weight398.45
-
Molecular FormulaC18H23FN2O5S?
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC(NCc1ccc(OCc2ccccc2F)cc1)C(N)=O.CS(=O)(=O)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Liang X Yu G Su R . Effects of ralfinamide in models of nerve injury and chemotherapy-induced neuropathic pain[J]. European journal of pharmacology 2018 823:27-34.
molnova catalog
related products
-
Ranolazine dihydroch...
An anti-ischemic agent that has been shown to inhibit late I(Na) and I(Kr) and to have antiarrhythmic effects in various preclinical in vitro models.
-
Carbamazepine
Carbamazepine, asodium channelblocker, is an anticonvulsant drug.
-
L-(-)-Fucose
Anti-infective, anti-cancer, enhance immunity.
